Post Market Safety Study and Effectiveness With Evolence in Subjects With Skin Color Types IV-VI
Public ClinicalTrials.gov record NCT00891774. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multi-Center, Prospective, Post Market Study to Assess the Safety and Effectiveness of EVOLENCE® in Facial Augmentation of Subjects With Fitzpatrick Skin Color Types IV, V, and VI
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Approximately 165 subjects with Fitzpatrick Skin Color Types IV, V, and VI and a moderate to deep wrinkle between the corner of the nose and the corner of the mouth, will be treated with EVOLENCE® (an approved collagen filler) to smooth and flatten that wrinkle. They will be observed for 6 months to establish safety of the product as it relates to scarring and changes in skin pigment, and long term effectiveness.
Study identification
- NCT ID
- NCT00891774
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 172 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 30, 2008
- Primary completion
- Nov 29, 2009
- Completion
- Nov 29, 2009
- Last update posted
- Feb 5, 2019
2008 – 2009
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The Vitiligo and Pigmentation Institute of Southern California | Los Angeles | California | 90036 | — |
| Desert Dermatology Medical Associates | Rancho Mirage | California | 92270 | — |
| Center for Dermatology and Dermatologic Surgery | Washington D.C. | District of Columbia | 20037 | — |
| Atlanta Dermatology Vein & Research Center | Alpharetta | Georgia | 30022 | — |
| Denova Research | Chicago | Illinois | 60611 | — |
| DuPage Medical Group Clinical Research | Naperville | Illinois | 60563 | — |
| Callender Center for Clinical Research | Mitchellville | Maryland | 20721 | — |
| The Boyd Gillard Institute of Aesthetic & Dermatology Surgery | Ypsilanti | Michigan | 48197 | — |
| Image Dermatology | Montclair | New Jersey | 07042 | — |
| Susan Taylor | Philadelphia | Pennsylvania | 19107 | — |
| Tennessee Clinical Research | Nashville | Tennessee | 37215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00891774, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 5, 2019 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00891774 live on ClinicalTrials.gov.